Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 worsens urinary symptoms in men with benign prostatic hyperplasia, requiring careful treatment management.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

The document listed medical job ads and guidelines for breast cancer screening.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Parental uveitis causes hair loss in offspring of C57BL/6J mice.

The document suggests recognizing "trichiatrists" as doctors specializing in hair and scalp health, using evidence-based treatments.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Both terazosin and baclofen effectively reduce pain in young men with chronic testicular pain, with no difference in their effectiveness.

Gold nanoparticles show promise for treating inflammatory bowel disease by reducing inflammation and colon injury.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.